PRO-DEX, INC. Noncash or Part Noncash Acquisition, Payables Assumed
PRO-DEX, INC. (PDEX) reported Noncash or Part Noncash Acquisition, Payables Assumed of $2.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1 · last filed 2026-09-03
- PRO-DEX, INC. noncash or part noncash acquisition, payables assumed for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- PRO-DEX, INC. noncash or part noncash acquisition, payables assumed for the quarter ending 2025-09-30 was $2.00K, a 99.46% decline year-over-year.
- PRO-DEX, INC. noncash or part noncash acquisition, payables assumed for the quarter ending 2025-06-30 was $327.00K, a 25.77% increase year-over-year.
- PRO-DEX, INC. noncash or part noncash acquisition, payables assumed for the quarter ending 2025-03-31 was $0.00.
- PRO-DEX, INC. noncash or part noncash acquisition, payables assumed for fiscal 2026 was $2.00K, a 99.86% decline from fiscal 2025.
- PRO-DEX, INC. noncash or part noncash acquisition, payables assumed for fiscal 2025 was $1.43M, a 327.25% increase from fiscal 2024.
- PRO-DEX, INC. noncash or part noncash acquisition, payables assumed for fiscal 2024 was $334.00K.
| Period end | Noncash or Part Noncash Acquisition, Payables Assumed 3 month | Noncash or Part Noncash Acquisition, Payables Assumed 6 month | Noncash or Part Noncash Acquisition, Payables Assumed 9 month | Noncash or Part Noncash Acquisition, Payables Assumed 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-03 | $2.00K 10-K · filed 2026-09-03 | ||
| 2026-03-31 | $2.00K 10-Q · filed 2026-04-30 | |||
| 2025-09-30 | $2.00K 10-Q · filed 2025-10-30 | $329.00K derived: sum of 2 quarters · filed 2026-09-03 | $329.00K derived: sum of 3 quarters · filed 2026-09-03 | $1.06M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-06-30 | $327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-03 | $327.00K derived: sum of 2 quarters · filed 2026-09-03 | $1.05M derived: sum of 3 quarters · filed 2026-09-03 | $1.43M 10-K · filed 2026-09-03 |
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-30 | $728.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.10M 10-Q · filed 2026-04-30 | $1.36M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $728.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-29 | $1.10M 10-Q · filed 2026-01-29 | $1.36M derived: sum of 3 quarters · filed 2026-01-29 | $1.36M derived: sum of 4 quarters · filed 2026-01-29 |
| 2024-09-30 | $372.00K 10-Q · filed 2025-10-30 | $632.00K derived: sum of 2 quarters · filed 2025-10-30 | $632.00K derived: sum of 3 quarters · filed 2025-10-30 | |
| 2024-06-30 | $260.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-04 | $260.00K derived: sum of 2 quarters · filed 2025-09-04 | $334.00K 10-K · filed 2025-09-04 | |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-01 | $74.00K 10-Q · filed 2025-05-01 | ||
| 2023-12-31 | $74.00K 10-Q · filed 2025-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |